Correlation Between Sangui Biotech and Cann American
Can any of the company-specific risk be diversified away by investing in both Sangui Biotech and Cann American at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sangui Biotech and Cann American into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sangui Biotech International and Cann American Corp, you can compare the effects of market volatilities on Sangui Biotech and Cann American and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sangui Biotech with a short position of Cann American. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sangui Biotech and Cann American.
Diversification Opportunities for Sangui Biotech and Cann American
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Sangui and Cann is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Sangui Biotech International and Cann American Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cann American Corp and Sangui Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sangui Biotech International are associated (or correlated) with Cann American. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cann American Corp has no effect on the direction of Sangui Biotech i.e., Sangui Biotech and Cann American go up and down completely randomly.
Pair Corralation between Sangui Biotech and Cann American
If you would invest 0.44 in Cann American Corp on September 13, 2024 and sell it today you would lose (0.12) from holding Cann American Corp or give up 27.27% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Sangui Biotech International vs. Cann American Corp
Performance |
Timeline |
Sangui Biotech Inter |
Cann American Corp |
Sangui Biotech and Cann American Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Sangui Biotech and Cann American
The main advantage of trading using opposite Sangui Biotech and Cann American positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sangui Biotech position performs unexpectedly, Cann American can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cann American will offset losses from the drop in Cann American's long position.Sangui Biotech vs. 4Front Ventures Corp | Sangui Biotech vs. Khiron Life Sciences | Sangui Biotech vs. BellRock Brands | Sangui Biotech vs. Elixinol Global |
Cann American vs. XCPCNL Business Services | Cann American vs. Golden Developing Solutions | Cann American vs. Indo Global Exchange | Cann American vs. Cgrowth Capital |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Complementary Tools
Global Correlations Find global opportunities by holding instruments from different markets | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data |